Graduate School of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan;
Department of Biological and Environmental Chemistry, Faculty of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan.
Cancer Genomics Proteomics. 2021 Jul-Aug;18(4):543-548. doi: 10.21873/cgp.20279.
BACKGROUND/AIM: The long noncoding RNA OIP5 antisense RNA 1 (OIP5-AS1) is overexpressed in various cancer types, such as lung cancer, hepatoblastoma and cervical cancer, and functions to accelerate cell proliferation, invasion and migration. Here, we investigated the roIe of OIP5-AS1 in cell-cycle progression of H1299 and A549 non-small cell lung cancer cells, and FaDu and CAL27 head and neck squamous cell carcinoma cells.
The cells were transfected with small interfering RNA and subjected to cell-cycle analysis and reverse-transcription quantitative polymerase chain reaction (RT-qPCR).
Silencing of OIP5-AS1 suppressed the proliferation of H1299, A549, FaDu and CAL27 cells. RT-qPCR and cell-cycle analysis revealed that silencing OIP5-AS1 increased the expression of CDK inhibitors, such as p15, p16, p18 and p19, resulting in G1-phase arrest.
OIP5-AS1 regulates G1-phase progression by repressing CDK inhibitors and, thus, promotes the proliferation of H1299, A549, FaDu and CAL27 cells.
背景/目的:长链非编码 RNA OIP5 反义 RNA 1(OIP5-AS1)在多种癌症类型中过表达,如肺癌、肝母细胞瘤和宫颈癌,其功能是加速细胞增殖、侵袭和迁移。在这里,我们研究了 OIP5-AS1 在 H1299 和 A549 非小细胞肺癌细胞以及 FaDu 和 CAL27 头颈部鳞状细胞癌细胞细胞周期进展中的作用。
用小干扰 RNA 转染细胞,并进行细胞周期分析和逆转录定量聚合酶链反应(RT-qPCR)。
沉默 OIP5-AS1 抑制了 H1299、A549、FaDu 和 CAL27 细胞的增殖。RT-qPCR 和细胞周期分析显示,沉默 OIP5-AS1 增加了 CDK 抑制剂的表达,如 p15、p16、p18 和 p19,导致 G1 期阻滞。
OIP5-AS1 通过抑制 CDK 抑制剂来调节 G1 期进展,从而促进 H1299、A549、FaDu 和 CAL27 细胞的增殖。